RevealDX Overview
- Year Founded
-
2014

- Status
-
Acquired/Merged
- Employees
-
9

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4.2M
- Investors
-
1
RevealDX General Information
Description
Developer of a clinical decision support technology designed to improve lung cancer outcomes. The company's technology delivers precision medicine targeted to support lung cancer decisions using artificial intelligence-enabled software, enabling clinicians to offer an optimal clinical pathway for treatments for patients.
Contact Information
Website
www.reveal-dx.com(Operating Subsidiary)
Corporate Office
- 1800 Westlake Avenue North
- Suite 104
- Seattle, WA 98109
- United States
Corporate Office
- 1800 Westlake Avenue North
- Suite 104
- Seattle, WA 98109
- United States
RevealDX Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
10. Later Stage VC | 23-Jul-2024 | $4.2M | Completed | Generating Revenue | ||
9. Later Stage VC | 16-Sep-2021 | Completed | Generating Revenue | |||
8. Merger/Acquisition | 23-Mar-2021 | Completed | Generating Revenue | |||
7. Later Stage VC | 15-Apr-2020 | Completed | Generating Revenue | |||
6. Later Stage VC | 01-Sep-2019 | Completed | Generating Revenue | |||
5. Early Stage VC | 01-Mar-2018 | Completed | Generating Revenue | |||
4. Early Stage VC (Series A) | 01-Jan-2018 | Completed | Generating Revenue | |||
3. Early Stage VC (Series A) | 15-Jun-2016 | Completed | Startup | |||
2. Seed Round | 05-May-2016 | $2M | $2.25M | Completed | Startup | |
1. Accelerator/Incubator | $250K | $250K | Completed | Startup |
RevealDX Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | ||||||||
Seed B | ||||||||
Seed | 749,999 | $0.000100 | 8% | $0.7 | $0.7 | 1x | $0.7 | 2.44% |
RevealDX Patents
RevealDX Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3030577-A1 | Medical analytics system | Inactive | 12-Jul-2016 | ||
EP-3485412-A1 | Medical analytics system | Inactive | 12-Jul-2016 | ||
EP-3485412-A4 | Medical analytics system | Inactive | 12-Jul-2016 | G16H50/20 |
RevealDX Signals
RevealDX Former Investors (10)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
A-Level Capital | Venture Capital | Minority | ||
Alliance of Angels | Angel Group | Minority | ||
Frontier Angels | Angel Group | Minority | ||
Frost Data Capital | Venture Capital | Minority | ||
Life Science Angels | Angel Group | Minority |
RevealDX FAQs
-
When was RevealDX founded?
RevealDX was founded in 2014.
-
Where is RevealDX headquartered?
RevealDX is headquartered in Seattle, WA.
-
What is the size of RevealDX?
RevealDX has 9 total employees.
-
What industry is RevealDX in?
RevealDX’s primary industry is Decision/Risk Analysis.
-
Is RevealDX a private or public company?
RevealDX is a Private company.
-
What is RevealDX’s current revenue?
The current revenue for RevealDX is
. -
How much funding has RevealDX raised over time?
RevealDX has raised $4.45M.
-
Who are RevealDX’s investors?
A-Level Capital, Alliance of Angels, Frontier Angels, Frost Data Capital, and Life Science Angels are 5 of 10 investors who have invested in RevealDX.
-
When was RevealDX acquired?
RevealDX was acquired on 23-Jul-2024.
-
Who acquired RevealDX?
RevealDX was acquired by Precision Medical Ventures.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »